Figure 2.

Adjusted mean intact parathyroid hormone levels and 95% confidence intervals calculated using a linear mixed model with each treatment group, time-point, and interaction of treatment group and time-point as fixed effects. Changes in each index are compared among treatment groups at each time-point using the Tukey-Kramer method to correct for multiplicity. (a) Comparison of etelcalcetide patients versus controls. (b) Etelcalcetide users corrected hypocalcemia by active vitamin D versus oral calcium preparation (Ca). ∗P < 0.05. iPTH, intact parathyroid hormone.